1,073
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation

, , , , &
Pages 1404-1412 | Received 13 Mar 2014, Accepted 13 Jul 2014, Published online: 21 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Umbreen Hafeez, Adam C Parslow, Hui K Gan & Andrew M Scott. (2020) New insights into ErbB3 function and therapeutic targeting in cancer. Expert Review of Anticancer Therapy 20:12, pages 1057-1074.
Read now
Yan Wang, Lina Wang, Xue Yu & Jianping Duan. (2019) Overexpression of miR-450 affects the biological behavior of HepG2 cells by targeting DNMT3a. OncoTargets and Therapy 12, pages 5069-5076.
Read now
Eric J Devor, Elizabeth Cha, Akshaya Warrier, Marina D Miller, Jesus Gonzalez-Bosquet & Kimberly K Leslie. (2018) The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes. OncoTargets and Therapy 11, pages 7205-7211.
Read now
Nadège Gaborit, Moshit Lindzen & Yosef Yarden. (2016) Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3. Human Vaccines & Immunotherapeutics 12:3, pages 576-592.
Read now

Articles from other publishers (26)

Roberto Mattioli, Andrea Ilari, Beatrice Colotti, Luciana Mosca, Francesco Fazi & Gianni Colotti. (2023) Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming. Molecular Aspects of Medicine 93, pages 101205.
Crossref
Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda & Takeshi Nakahara. (2023) Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Cell Death Discovery 9:1.
Crossref
Guiqing Zhou, Ji Wang, Lihua Ren, Jianhui Liu, Xiangyang Li, Yue Zhang, Yujian Sang, Leqiang Gao, Yanbo Li, Zhiwei Sun & Xianqing Zhou. (2023) Silica nanoparticles suppressed the spermatogenesis via downregulation of miR-450b-3p by targeting Layilin in spermatocyte of mouse. Environmental Pollution 318, pages 120864.
Crossref
Lucía Gandullo-Sánchez, Alberto Ocaña & Atanasio Pandiella. (2022) HER3 in cancer: from the bench to the bedside. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Zhongshi Hong, Jianpeng Pan, Mingliang Chen, Xian Deng, Zhichuan Chen, Chunxiao Wang & Chengzhi Qiu. (2022) Long Intergenic Noncoding RNA 00641 Promotes Growth and Invasion of Colorectal Cancer through Regulating miR-450b-5p/GOLPH3 Axis. Journal of Oncology 2022, pages 1-16.
Crossref
Sina Taefehshokr, Nima Taefehshokr, Afshin Derakhshani, Amir Baghbanzadeh, Reza Vaezi Astamal, Sahar Safaei, Samane Abbasi, Saba Hajazimian, Nazila Fathi Maroufi, Alireza Isazadeh, Khalil Hajiasgharzadeh & Behzad Baradaran. (2022) The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer. Current Molecular Medicine 22:3, pages 263-273.
Crossref
Iris Garrido-Cano, Birlipta Pattanayak, Anna Adam-Artigues, Ana Lameirinhas, Sandra Torres-Ruiz, Eduardo Tormo, Raimundo Cervera & Pilar Eroles. (2021) MicroRNAs as a clue to overcome breast cancer treatment resistance. Cancer and Metastasis Reviews 41:1, pages 77-105.
Crossref
Zahra Torki, Davood Ghavi, Solmaz Hashemi, Yazdan Rahmati, Dara Rahmanpour, Majid Pornour & Mohammad Reza Alivand. (2021) The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update. Cancer Chemotherapy and Pharmacology 88:5, pages 771-793.
Crossref
Heidi M. Haikala & Pasi A. Jänne. (2021) Thirty Years of HER3: From Basic Biology to Therapeutic Interventions. Clinical Cancer Research 27:13, pages 3528-3539.
Crossref
Guiqing Zhou, Jianhui Liu, Xiangyang Li, Yujian Sang, Yue Zhang, Leqiang Gao, Ji Wang, Yang Yu, Wei Ge, Zhiwei Sun & Xianqing Zhou. (2021) Silica nanoparticles inducing the apoptosis via microRNA-450b-3p targeting MTCH2 in mice and spermatocyte cell. Environmental Pollution 277, pages 116771.
Crossref
Juan Yao, Hao Zhang, Cheng Liu, Shuangshuang Chen, Rongyu Qian & Kun Zhao. (2020) miR-450b-3p inhibited the proliferation of gastric cancer via regulating KLF7. Cancer Cell International 20:1.
Crossref
David J. Ford, Claudia B. Zraly, John Hertenstein Perez & Andrew K. Dingwall. (2020) The Drosophila MLR COMPASS-like complex regulates bantam miRNA expression differentially in the context of cell fate. Developmental Biology 468:1-2, pages 41-53.
Crossref
Li Han, Xiaoying Zhang, Aimin Wang, Yang Ji, Xuelei Cao, Qiaoji Qin, Tao Yu, Huan Huang & Lei Yin. (2020) A Dual-Circular RNA Signature as a Non-invasive Diagnostic Biomarker for Gastric Cancer. Frontiers in Oncology 10.
Crossref
Zide Chen, Wenhang Zhuang, Zeju Wang, Weiliang Xiao, Wei Don, Xianming Li & Xiaoming Chen. (2019) MicroRNA‐450b‐3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma. Journal of Cellular Biochemistry 120:11, pages 18805-18815.
Crossref
Yan‐Xing Guan, Meng‐zhi Zhang, Xue‐Zhong Chen, Qing Zhang, Shao‐Zheng Liu & Yong‐Lu Zhang. (2018) Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR‐495. Journal of Cellular Biochemistry 119:10, pages 7971-7981.
Crossref
Hong-xiang Wang, Qi-lin Huang, Jun-yan Shen, Tao Xu, Fan Hong, Zhen-yu Gong, Feng Li, Yong Yan & Ju-xiang Chen. (2018) Expression profile of circular RNAs in IDH-wild type glioblastoma tissues. Clinical Neurology and Neurosurgery 171, pages 168-173.
Crossref
Alessandra Cataldo, Claudia Piovan, Ilaria Plantamura, Elvira D’Ippolito, Simone Camelliti, Patrizia Casalini, Marta Giussani, Olivier Déas, Stefano Cairo, Jean-Gabriel Judde, Elda Tagliabue & Marilena V. Iorio. (2018) MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab. Oncotarget 9:46, pages 27920-27928.
Crossref
Xiyong Wang, Xiaoli Zhu, Hongming Zhang, Shuzhen Wei, Yan Chen, Yang Chen, Fei Wang, Xiaobo Fan, Shuhua Han & Guoqiu Wu. (2018) Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation. Biochemical and Biophysical Research Communications 496:4, pages 1069-1075.
Crossref
Heena Singla, Abhilash Ludhiadch, Raman Preet Kaur, Harish Chander, Vinod Kumar & Anjana Munshi. (2017) Recent advances in HER2 positive breast cancer epigenetics: Susceptibility and therapeutic strategies. European Journal of Medicinal Chemistry 142, pages 316-327.
Crossref
Xianqiu Li, Zhaoling An, Peihui Li & Haihua Liu. (2017) A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs. Oncology Letters 14:3, pages 2991-2995.
Crossref
Janet A. Grimes, Nripesh Prasad, Shawn Levy, Russell Cattley, Stephanie Lindley, Harry W. Boothe, Ralph A. Henderson & Bruce F. Smith. (2016) A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs. BMC Veterinary Research 12:1.
Crossref
Sweta Sharma Saha, Rahul Roy Chowdhury, Nidhu Ranjan Mondal, Biman Chakravarty, Tanmay Chatterjee, Sudipta Roy & Sharmila Sengupta. (2016) Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis. Cellular Oncology 39:6, pages 559-572.
Crossref
Ling Mao, Ai-jun Sun, Jian-zhong Wu & Jin-hai Tang. (2016) Involvement of microRNAs in HER2 signaling and trastuzumab treatment. Tumor Biology 37:12, pages 15437-15446.
Crossref
Bernhard Biersack. (2016) Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention. Non-coding RNA Research 1:1, pages 12-34.
Crossref
Ya-Ping Ye, Ping Wu, Chun-cai Gu, Dan-ling Deng, Hong-Li Jiao, Ting-Ting Li, Shu-Yang Wang, Yong-Xia Wang, Zhi-Yuan Xiao, Wen-ting Wei, Yan-Ru Chen, Jun-Feng Qiu, Run-Wei Yang, Jie Lin, Li Liang, Wen-Ting Liao & Yan-Qing Ding. (2016) miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Oncotarget 7:38, pages 61312-61324.
Crossref
Josiah Cox & Steven Weinman. (2016) Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepatic Oncology 3:1, pages 57-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.